MyFinsight
Home
Compare
About
Recent SEC Filings
10/6
Lamb Weston Holdings, Inc.
(LW)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/6
Lamb Weston Holdings, Inc.
(LW)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
U S PHYSICAL THERAPY INC NV (USPH)
U S PHYSICAL THERAPY INC NV (USPH)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Change in Cash
-$2,984K
Free Cash flow
$15,625K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from revolving facility
Net income including non-control...
Depreciation and amortization
Others
Negative Cash Flow Breakdown
Payments on revolving facility
Purchase of interest in business...
Cash dividends paid to sharehold...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-09-30
2025-06-30
Net income including non-controlling interest
17,642
31,188
Depreciation and amortization
5,832
11,924
Provision for credit losses
2,073
3,843
Equity-based awards compensation expense
2,263
3,888
Amortization of debt issue costs
105
210
Change in deferred income taxes
3,884
7,279
Change in revaluation of put-right liability
-663
-743
Change in fair value of contingent earn-out consideration
5,872
5,612
Equity of earnings in unconsolidated affiliate
361
794
Loss on sale of fixed assets
18
-438
Loss on sale of a partnership
0
-123
Other
0
-
Patient accounts receivable, net
3,372
10,232
Accounts receivable - other
-3,204
-355
Other current and long term assets
3,729
4,426
Accounts payable and accrued expenses
-2,994
-7,914
Other long-term liabilities
620
-827
Net cash provided by operating activities
19,940
30,186
Purchase of fixed assets
4,315
5,830
Purchase of interest in businesses, net of cash acquired
8,324
6,890
Purchase of redeemable non-controlling interest, temporary equity
152
8,427
Repayment of notes receivable related to redeemable non-controlling interest
-
346
Purchase of non controlling interest, permanent equity
47
149
Proceeds from the sale of non-controlling interest, permanent equity
0
9
Proceeds from the sale of partnership interest - redeemable non-controlling interest, temporary equity
134
15
Repayment of notes receivable related to sales of redeemable non-controlling interest
387
-
Proceeds from the sale of partnership
0
700
Distributions from unconsolidated affiliate
425
664
Other
-303
-228
Net cash (used in) investing activities
-11,935
-19,334
Proceeds from revolving facility
73,000
73,500
Payments on revolving facility
71,000
60,000
Distributions to non-controlling interest, permanent and temporary equity
3,913
10,697
Cash dividends paid to shareholders
6,842
13,678
Payments on term loan
1,875
5,625
Principal payments on notes payable
366
1,628
Other
7
-
Net cash (used in) financing activities
-10,989
-18,128
Net (decrease) in cash and cash equivalents
-2,984
-7,276
Cash and cash equivalents at beginning of period
41,362
-
Cash and cash equivalents at end of period
31,102
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
USPH Cash Flow Sankey Diagram
Sankey diagram visualizing USPH cash flow for the period
Net income
including...
$17,642K
Depreciation and
amortization
$5,832K
Change in deferred
income taxes
$3,884K
Accounts receivable -
other
-$3,204K
Equity-based awards
compensation expense
$2,263K
Provision for credit
losses
$2,073K
Change in revaluation
of put-right...
-$663K
Other long-term
liabilities
$620K
Amortization of debt issue
costs
$105K
Net cash provided by
operating activities
$19,940K
Canceled cashflow
$16,346K
Net (decrease) in
cash and cash...
-$2,984K
Canceled cashflow
$19,940K
Distributions from
unconsolidated affiliate
$425K
Repayment of notes
receivable related to sales...
$387K
Other
-$303K
Proceeds from the sale of
partnership interest -...
$134K
Proceeds from revolving
facility
$73,000K
Other
$7K
Change in fair value of
contingent earn-out...
$5,872K
Other current and long
term assets
$3,729K
Patient accounts
receivable, net
$3,372K
Accounts payable and
accrued expenses
-$2,994K
Equity of earnings in
unconsolidated affiliate
$361K
Loss on sale of fixed
assets
$18K
Net cash (used in)
investing activities
-$11,935K
Canceled cashflow
$1,249K
Net cash (used in)
financing activities
-$10,989K
Canceled cashflow
$73,007K
Purchase of interest in
businesses, net of cash...
$8,324K
Purchase of fixed assets
$4,315K
Purchase of redeemable
non-controlling interest,...
$152K
Purchase of non
controlling interest,...
$47K
Payments on revolving
facility
$71,000K
Cash dividends paid
to shareholders
$6,842K
Distributions to
non-controlling interest,...
$3,913K
Payments on term loan
$1,875K
Principal payments on
notes payable
$366K
Buy us a coffee